Home › Mutual Funds › Tata Mutual Fund › Tata India Pharma & Healthcare Fund Regular Growth
Latest NAV & returns of TATA ASSET MANAGEMENT LTD.

Tata India Pharma & Healthcare Fund Regular Growth

Add To Compare

29.602 (0.469%)
NAV on February 16, 2026
Category Equity:
Sector - Healthcare
Investment StyleBox
Mid Growth
Total Assets 1,240 cr
Turnover Ratio 11.18%
Expense Ratio 2.14%
Exit Load 0.25%if redeemed within
30 Days0.00%if redeemed after 30 Days
Returns
  • 1M: -0.40%
  • 1Y: 6.15%
  • 3M: -4.24%
  • 3Y: 21.93%
  • 6M: -4.62%
  • 5Y: 14.29%
Min Investment 5,000
ADDITIONAL INFO
Fund Manager Rajat Srivastava (Since over 1 year)
ISIN INF277K016A9
Fund Family Tata
P/E Ratio 41.36
P/B Ratio 6.57
Launch Date December 28, 2015
Benchmark Nifty Pharma TR INR
ASSET ALLOCATION
EQUITY DISTRIBUTION
RISK MEASURES (3 yrs)
vs Nifty Pharma TR INR

Alpha -0.08
Beta 0.94
R-Squared 94.89
Info Ratio -0.26
Tracking Err 3.81
Sortino 1.447
Sharpe 0.839
Std Dev 16.344
Risk -
SECTOR WEIGHTINGS (%)
Financial 0.0%
Industrial 0.0%
Technology 0.0%
Basic Materials 3.38%
Consumer Cyclical 0.0%
Utilities Services 0.0%
Healthcare Services 96.62%
Energy Services 0.00%
Communication Services 0.00%
Consumer Defensive 0.00%
Real Estate 0.00%
INVESTMENT OBJECTIVE

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

View Factsheet
-


Other plans of Tata India Pharma & Healthcare


Other Equity funds by Tata

Data Partner
Click here to visit AMC website and
read all scheme related documents Tata Fund